CBLL
CeriBell Inc.
Company Overview
| Mkt Cap | $735.89M | Price | $20.80 |
| Volume | 194.18K | Change | -1.61% |
| P/E Ratio | -18.2 | Open | $21.09 |
| Revenue | $65.4M | Prev Close | $21.14 |
| Net Income | $-40.5M | 52W Range | $10.85 - $24.33 |
| Div Yield | N/A | Target | $27.57 |
| Overall | 56 | Value | 50 |
| Quality | 52 | Technical | 66 |
No chart data available
About CeriBell Inc.
CeriBell, Inc. operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States. The company develops Ceribell System, a novel and point-of-care electroencephalography (EEG) platform to address the unmet needs of patients in the acute care setting. It also offers disposable headbands consists of ten non-invasive electrodes pre-filled with conductive gel; and pocket-sized battery-operated recorders designed to record and store EEG signals generated by the headband. In addition, the company provides Clarity, an AI-powered seizure detection algorithm. Further, it operates Ceribell EEG portal, a cloud-based secured portal that enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
Latest News
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
Ceribell Targets ICU Delirium With New EEG Study, Signaling Wider Market Ambitions
TD Cowen Sticks to Its Buy Rating for Ceribell, Inc. (CBLL)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CBLL | $20.80 | -1.6% | 194.18K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |